Skip to main navigation Skip to search Skip to main content

SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine

  • Warren S. Alexander
  • , Robyn Starr
  • , Jennifer E. Fenner
  • , Clare L. Scott
  • , Emanuela Handman
  • , Naomi S. Sprigg
  • , Jason E. Corbin
  • , Ann L. Cornish
  • , Rima Darwiche
  • , Catherine M. Owczarek
  • , Thomas W.H. Kay
  • , Nicos A. Nicola
  • , Paul J. Hertzog
  • , Donald Metcalf
  • , Douglas J. Hilton

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Mice lacking suppressor of cytokine signaling-1 (SOCS1) develop a complex fatal neonatal disease. In this study, SOCS1(-/-) mice were shown to exhibit excessive responses typical of those induced by interferon γ (IFNγ), were hyperresponsive to viral infection, and yielded macrophages with an enhanced IFNγ-dependent capacity to kill L. major parasites. The complex disease in SOCS1(-/-) mice was prevented by administration of anti- IFNγ antibodies and did not occur in SOCS1(-/-) mice also lacking the IFNγ gene. Although IFNγ is essential for resistance to a variety of infections, the potential toxic action of IFNγ, particularly in neonatal mice, appears to require regulation. Our data indicate that SOCS1 is a key modulator of IFNγ action, allowing the protective effects of this cytokine to occur without the risk of associated pathological responses.

Original languageEnglish
Pages (from-to)597-608
Number of pages12
JournalCell
Volume98
Issue number5
DOIs
Publication statusPublished - 3 Sept 1999

Cite this